VELOCITY FUND PARTNERS, LP - 31 Dec 2024 Form 3/A - Amendment Insider Report for Medicus Pharma Ltd. (MDCX)

Role
10%+ Owner
Signature
/s/ Kenneth R. Melani, General Partner of Velocity Fund Partners, LP
Issuer symbol
MDCX
Transactions as of
31 Dec 2024
Net transactions value
$0
Form type
3/A - Amendment
Filing time
21 May 2025, 16:21:04 UTC
Date Of Original Report
31 Dec 2024
Next filing
21 May 2025
SEC
View on sec.gov

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
VELOCITY FUND PARTNERS, LP 10%+ Owner 1100 STONEGATE MANOR, CHESWICK /s/ Kenneth R. Melani, General Partner of Velocity Fund Partners, LP 21 May 2025 0001671948
Melani Kenneth R. 10%+ Owner 1100 STONEGATE MANOR, CHESWICK /s/ Kenneth R. Melani 21 May 2025 0002050471

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MDCX Common Shares, no par value ("Common Shares") 2,914,330 31 Dec 2024 See Footnote F1
holding MDCX Common Shares 409,411 31 Dec 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by Velocity Fund Partners, LP, an entity controlled by Dr. Kenneth R. Melani. Dr. Kenneth R. Melani disclaims beneficial ownership except to the extent of his pecuniary interest therein.

Remarks:

The initial Form 3 that was filed on December 31, 2024, is being amended solely to add Velocity Fund Partners, LP as a Reporting Owner.